Drug pricing debates: Can we quantify what a life’s worth? Posted on October 11, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biopharmaceutical, Biotech, Drug Costs, Health Policy, Pharmaceuticals, Quality of Life • Leave a comment Drug pricing debates: Can we quantify what a life’s worth? Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Washington state’s life sciences companies shatter records with more than $3B in deals Posted on October 10, 2015 by henrykotula • Posted in Uncategorized • Tagged Biopharmaceutical, Biotech, IPO, Life Sciences, M&A, Venture Capital • Leave a comment http://www.bizjournals.com/seattle/blog/health-care-inc/2015/10/washington-states-life-sciences-companies-shatter.html?ana=e_ptl_hc&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1444506012 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Soon-Shiong back to his roots: NantWorks acquires next-gen Abraxane in potential $1.3B deal Posted on May 16, 2015 by henrykotula • Posted in Uncategorized • Tagged Biopharmaceutical, Biotech, Cancer Treatment, Healthcare, Precision Cancer Medicine • Leave a comment Soon-Shiong back to his roots: NantWorks acquires next-gen Abraxane in potential $1.3B deal Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Medtech venture capital: Opportunistic vs. commitment styles of investment Posted on May 8, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biopharmaceutical, Biotech, Private Equity, Venture Capital • Leave a comment Medtech venture capital: Opportunistic vs. commitment styles of investment Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Bringing blood irradiation back en vogue: Startup uses UV phototherapy treat infections in the bloodstream Posted on February 28, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biopharmaceutical, Blood Irradiation, Bloodstream Infections, Healthcare, UV Phototherapy • Leave a comment Bringing blood irradiation back en vogue: Startup uses UV phototherapy treat infections in the bloodstream Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Who is going to defeat the superbug (because federal policies sure aren’t working)? Posted on February 28, 2015 by henrykotula • Posted in Uncategorized • Tagged Antibiotic Resistance, Biomed, Biopharmaceutical, CRE, Healthcare, Superbug • Leave a comment Who is going to defeat the superbug (because federal policies sure aren’t working)? Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Why Society Needs a Vibrant Pharmaceutical Industry: Improving Patients’ Lives Posted on June 16, 2014 by henrykotula • Posted in Uncategorized • Tagged Biopharmaceutical • Leave a comment https://www.linkedin.com/today/post/article/20140612143605-322581966-why-society-needs-a-vibrant-pharmaceutical-industry-improving-patients-lives?trk=cha-feed-art-title-217 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Biopharmaceutical industry: Where investment opportunities outweigh the risks Posted on December 13, 2013 by henrykotula • Posted in Uncategorized • Tagged Biopharmaceutical, Trends • Leave a comment Biopharmaceutical industry: Where investment opportunities outweigh the risks Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
HENRY KOTULA 